IMDX
Insight Molecular Diagnostics
IMDX
IMDX
54 hedge funds and large institutions have $39.8M invested in Insight Molecular Diagnostics in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.02% less ownership
Funds ownership: 1.55% → 1.54% (-0.02%)
7% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 15
38% less capital invested
Capital invested by funds: $63.7M → $39.8M (-$23.9M)
Holders
54
Holding in Top 10
1
Calls
$25K
Puts
$9K
Top Buyers
| 1 | +$3.56M | |
| 2 | +$877K | |
| 3 | +$550K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$390K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$319K |
Top Sellers
| 1 | -$5.09M | |
| 2 | -$1.69M | |
| 3 | -$670K | |
| 4 |
Renaissance Technologies
New York
|
-$538K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$427K |